 - Concurrent participation in any other HIV prevention trial or drugvaccine safety trial. AIDSVAX BE HIV vaccine trial CDC protocol 2076 participants and Extension Study CDC protocol 3750 participants may be screened for enrollment in the Bangkok Tenofovir Study. 